Skip to main content
S&P 5007,586.35-0.65%DOW51,966.20-0.79%NASDAQ26,077.59-0.67%BTC$77,165.00-1.57%ETH$2,465.13-0.56%GOLD$4,372.50-1.98%OIL$101.69+5.87%
Smart Investors Daily
GG

NASDAQ · GGAA

Genesis Growth Tech Acquisition Corp.

Financial Services · Shell Companies

$21.57

Up+$9.67 (+81.26%)

Updated Sep 10, 2026, 7:09 PM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
138.61M
P/E ratio
328.41
Dividend yield
0.00%
52-week range
— – —
Volume
2.14M
Avg. volume
53.92K

Price performance

GGAA price history

1M range · 0 trading sessions · Daily adjusted prices

GGAA does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest GGAA news

The latest Smart Investors Daily articles mentioning GGAA.

Stock researchCompany · Overview

GGAA research

Overview

Company profile and research snapshot.

Company profile

Genesis Growth Tech Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus its efforts on identifying technology companies operating primarily within the consumer internet industry in Europe, Israel, the United Arab Emirates, or the United States. The company was incorporated in 2021 and is based in Hergiswil, Switzerland.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Jul 14, 2023

Genesis Growth Tech Acquisition Corp. Announces Receipt of Nasdaq Delisting Notification

NIDWALDEN, Switzerland, July 14, 2023 (GLOBE NEWSWIRE) -- Genesis Growth Tech Acquisition Corp. (Nasdaq: GGAA) (“GGAA” or “Genesis”), today announced that on July 14, 2023, it received a notice (“Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”). The Notice advised the Company that for the 30 consecutive trading days ending June 27, 2023, the Company’s average market value of listed securities has been below $50 million and the average market value of publicly held securities for its Class A ordinary shares has been below $40 million, and as a result, the Company was not in compliance with Nasdaq Listing Rule 5452 and that Nasdaq has determined to delist the Company’s securities (units, ordinary shares and warrants).

GlobeNewswire Inc. · May 26, 2023

Genesis Growth Tech Acquisition Corp. Receives Notice from Nasdaq Regarding Delayed Quarterly Report

NIDWALDEN, Switzerland, May 26, 2023 (GLOBE NEWSWIRE) -- Genesis Growth Tech Acquisition Corp. (Nasdaq: GGAA) (“GGAA” or “Genesis”), announced today that it had received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating GGAA was not in compliance with Nasdaq Listing Rule 5250(c)(1), as a result of not having timely filed its Quarterly Report on Form 10-Q for the period ended March 31, 2023 and for remaining delinquent in filing its Annual Report on Form 10-K for the year ended December 31, 2022.

Benzinga · May 24, 2023

Agilent, PTC Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. PTC Therapeutics, Inc. (NASDAQ: PTCT) shares dipped 21.3% to $46.00 in pre-market trading after the company announced its MOVE-FA trial of vatiquinone did not meet its primary endpoint. The company will discontinue its preclinical and early research gene therapy programs. Global Net Lease, Inc. (NYSE: GNL) shares fell 10.4% to $9.46 ...

Benzinga · Mar 7, 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the European market. EUDA Health Holdings Limited (NASDAQ: EUDA) surged 53.1% to $2.94. Assure Holdings Corp. (NASDAQ: IONM) jumped 41.2% to $6.86. Unicycive Therapeutics, Inc. (NASDAQ: UNCY) gained 36% to $1.69 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb. WW International, Inc. (NASDAQ: WW) shares gained 29.8% to $5.02 despite worse-than-expected Q4 revenue and Q1 guidance below estimates. The company also announced it will acquire Weekend Health, Inc. for a net purchase price of $106 million. ThredUp Inc. (NASDAQ: TDUP) jumped 29% to $2.0892 after the company reported better-than-expected Q4 sales and issued strong Q1 guidance. Gaia, Inc. (NASDAQ: GAIA) gained 24% to $3.2588 following Q4 results. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) rose 21.3% to $0.51 after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) gained 20% to $18.25 after the company announced JNJ-2113 met its primary endpoint in the Phase 2b FRONTIER 1 clinical trial in psoriasis. Novo Integrated Sciences, Inc. (NASDAQ: NVOS) rose 18.9% to $0.2069 after jumping around 35% on Monday. ATA Creativity Global (NASDAQ: AACG) shares rose 18.4% to $2.31. ATA Creativity, during November, posted a rise in quarterly sales. Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) jumped 17.4% to $3.24. Allakos Inc. (NASDAQ: ALLK) gained 17% to $6.32 following a narrower-than-expected quarterly ...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By